Tag: data integrity

ADaM Derivations You Can Defend: Versioning, Unit Tests, Rationale

November 5, 2025

ADaM Derivations You Can Defend: Versioning, Unit Tests, Rationale ADaM Derivations You Can Defend: Versioning Discipline, Unit Tests That Catch Drift, and Rationale You Can Read in Court Outcome-first ADaM: derivations that survive questions, re-cuts, and inspection sprints What “defensible” means in practice Defensible ADaM derivations are those that a new reviewer can trace, reproduce,…

Biostats, CDISC & Traceability, Clinical Trial Operations & Data Integrity

How Inspectors Review Source Data and Systems

September 9, 2025

digi

How Inspectors Review Source Data and Systems Inspector Expectations for Reviewing Source Data and Clinical Systems Understanding the Role of Source Data in Inspections Source data forms the foundation of clinical trial evidence and includes the original records and observations related to trial subjects. This data must support the entries made in the Case Report…

Audit Trails and Inspection Readiness, Regulatory Inspection Types (Routine, For-Cause)

Handling Data Corrections in EDC Systems

August 30, 2025

digi

Handling Data Corrections in EDC Systems Managing Data Corrections in EDC Systems for Regulatory Compliance Why Data Corrections in EDC Systems Require Rigorous Oversight Data corrections are a normal part of clinical trial operations. Investigators may need to revise information previously entered into an Electronic Data Capture (EDC) system due to typographical errors, source data…

Audit Trail Reviews in EDC, Audit Trails and Inspection Readiness

Decentralized Data Capture in Global Rare Disease Trials

August 20, 2025

digi

Decentralized Data Capture in Global Rare Disease Trials Transforming Rare Disease Clinical Trials with Decentralized Data Capture The Shift Toward Decentralized Data Models Global rare disease trials face significant logistical and operational challenges. With patients often scattered across different countries and continents, traditional on-site data collection models result in delays, cost overruns, and participant burden….

Data & Technology, Rare and Orphan Disease Trials

ICH Guidelines on eTMF Audit Requirements

August 19, 2025

digi

ICH Guidelines on eTMF Audit Requirements How ICH Guidelines Shape Audit Requirements for eTMF Systems ICH GCP Overview: A Foundation for Audit Trail Expectations The International Council for Harmonisation (ICH) Good Clinical Practice (GCP) guidelines provide the gold standard framework for managing clinical trial documentation, including expectations around audit trails. Specifically, ICH E6(R2) emphasizes that…

Audit Trails and Inspection Readiness, TMF and eTMF Audit Trails

Handling Incidental Findings in Genetic Rare Disease Studies

August 19, 2025

digi

Handling Incidental Findings in Genetic Rare Disease Studies Managing Incidental Genetic Findings in Rare Disease Clinical Research Understanding the Challenge of Incidental Findings Advances in next-generation sequencing and genomic profiling have revolutionized rare disease research. However, these technologies often yield incidental findings—genetic results unrelated to the primary research question but potentially significant for a participant’s…

Ethics & Patient Engagement, Rare and Orphan Disease Trials

Understanding Audit Trails in eTMF Systems

August 18, 2025

digi

Understanding Audit Trails in eTMF Systems Comprehensive Guide to Audit Trails in eTMF Systems for Inspection Readiness What Are Audit Trails in eTMF Systems and Why Do They Matter? Audit trails in electronic Trial Master File (eTMF) systems play a critical role in documenting the “who, what, when, and why” of every activity that occurs…

Audit Trails and Inspection Readiness, TMF and eTMF Audit Trails

Managing Long-Term Sample Storage for Rare Disease Research

August 18, 2025

digi

Managing Long-Term Sample Storage for Rare Disease Research Best Practices for Long-Term Storage of Biological Samples in Rare Disease Trials Why Long-Term Sample Storage Is Critical in Rare Disease Research Long-term biological sample storage is an essential component of rare disease clinical trials. Due to the small number of patients and the progressive nature of…

Operational Challenges, Rare and Orphan Disease Trials

Data Ownership and Consent in Rare Disease Research

August 18, 2025

digi

Data Ownership and Consent in Rare Disease Research Understanding Data Ownership and Consent in Rare Disease Clinical Research The Rising Importance of Data in Rare Disease Trials Data is the cornerstone of rare disease research. With small patient populations, each data point—whether from a clinical trial, registry, or biobank—carries immense scientific and clinical value. However,…

Ethics & Patient Engagement, Rare and Orphan Disease Trials

Conducting QA Audits in Rare Disease Clinical Trials

August 15, 2025

digi

Conducting QA Audits in Rare Disease Clinical Trials How to Effectively Conduct QA Audits in Rare Disease Clinical Trials The Importance of QA Audits in Orphan Drug Development Quality Assurance (QA) audits are vital in clinical research, serving as a proactive tool to ensure Good Clinical Practice (GCP) compliance, data integrity, and regulatory readiness. In…

Operational Challenges, Rare and Orphan Disease Trials